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Abstract
Background  and  objectives:  Few  investigations  have  addressed  the  safety  of  oxygen  from  con-
centrators for  use  in  anesthesia  in  association  with  nitrous  oxide.  This  study  evaluated  the
percent  of  oxygen  from  a  concentrator  in  association  with  nitrous  oxide  in  a  semi-closed
rebreathing circuit.
Methods: Adult  patients  undergoing  low  risk  surgery  were  randomly  allocated  into  two  groups,
receiving a  fresh  gas  ﬂow  of  oxygen  from  concentrators  (O293)  or  of  oxygen  from  concentrators
and  nitrous  oxide  (O293N2O).  The  fraction  of  inspired  oxygen  and  the  percentage  of  oxygen  from
fresh  gas  ﬂow  were  measured  every  10  min.  The  ratio  of  FiO2/oxygen  concentration  delivered
was  compared  at  various  time  intervals  and  between  the  groups.
Results:  Thirty  patients  were  studied  in  each  group.  There  was  no  difference  in  oxygen  from
concentrators over  time  for  both  groups,  but  there  was  a  signiﬁcant  improvement  in  the  FiO2
(p  <  0.001)  for  O293  group  while  a  signiﬁcant  decline  (p  <  0.001)  for  O293N2O.  The  FiO2/oxygen
ratio  varied  in  both  groups,  reaching  a  plateau  in  the  O293  group.  Pulse  oximetry  did  not  fall
below  98.5%  in  either  group.
Conclusion: The  FiO2 in  the  mixture  of  O293  and  nitrous  oxide  fell  during  the  observation  period
although oxygen  saturation  was  higher  than  98.5%  throughout  the  study.  Concentrators  can  be
considered  a  stable  source  of  oxygen  for  use  during  short  anesthetic  procedures,  either  pure  or
in  association  with  nitrous  oxide  at  50:50  volume.
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the delivered  oxygen  concentration  from  concentrator  over
time (Friedman  repeated  measures  ANOVA,  p  =  0.084).  There
was a  signiﬁcant  improvement  in  the  FiO2 (p  <  0.001),  which
was lower  at  10  min  compared  to  40  min  and  up,  and  from
Table  1  Patients’  characteristics.
O293Mean  ±  SD  O293NOMean  ±  SD
Age  in  years  39.5  ±  18.3  32.9  ±  13.7
Weight (kg)  67.5  ±  12.9  70.2  ±  14.6Oxygen  concentrators  performance  
Introduction
The  high  price  of  oxygen  can  encourage  the  installation  of
oxygen concentrators.1,2 In  Brazil  a  previous  investigation
suggested that  savings  related  to  the  use  of  a  concentrator
over 10  years  in  a  non-proﬁt  hospital  reached  19.5  million
dollars.3 The  oxygen  from  concentrators  represents  a  cost
of US$  0.0015  mL−1.  It  is  worth  to  notice  the  offering  of  this
system as  an  oxygen  source  set  up  a  perfect  competition  in
this market  in  Brazil  and  reduced  its  ﬁnal  price  nationwide.
A  number  of  studies  using  oxygen  concentrators  with
open ventilation  systems  concluded  that  the  efﬁcacy  and
reliability of  such  devices  make  them  a  suitable  alternative
to oxygen  cylinders  in  the  developing  world.4--6
Oxygen  concentrators  use  zeolite  molecular  sieve  tech-
nology, which  can  produce  up  to  95%  pure  O2.  Brieﬂy,  room
air is  drawn  into  the  oxygen  concentrator  through  a  series
of ﬁlters  to  remove  dust  and  bacteria.  The  concentrator
contains two  columns  of  the  zeolite  molecular  sieve  within
a canister.  The  sieve  adsorbs  nitrogen  from  the  air  as  it
is forced  through  under  pressure.  The  sieve  allows  O2 to
pass through  along  with  the  0.93%  argon  present  in  the  air.
Synthetic zeolite  is  used  for  the  production  of  oxygen.  The
concentrator has  been  shown  to  be  reliable  and  cost  effec-
tive for  providing  oxygen  in  locations  where  cylinders  may
not always  be  available.7 However,  little  is  known  about  the
association of  oxygen  from  concentrators  with  nitrous  oxide
during mechanical  ventilation  in  anesthesia.
This  study  evaluated  the  percent  of  oxygen  from  a  con-
centrator in  association  with  nitrous  oxide  for  procedures
lasting at  least  100  min  in  a  semi-closed  rebreathing  circuit.
Methods
After  approval  by  the  Ethics  Research  Committee  of  Hospi-
tal Geral  de  Bonsucesso  do  Ministério  da  Saúde,  city  of  Rio
de Janeiro,  adult  patients  undergoing  low  risk  surgery  were
invited to  participate,  gave  written  informed  consent  and
were randomly  allocated  into  two  groups,  either  receiving
a fresh  gas  ﬂow  (FGF)  of  1000  mL  min−1 oxygen  from  con-
centrator (O293)  or  a  FGF  of  500  mL  min−1 of  oxygen  from
concentrator plus  500  mL  min−1 nitrous  oxide  (O293NO).  The
only exclusion  criterion  was  the  presence  of  any  lung  dis-
ease. The  oxygen  used  in  this  investigation  was  provided
by oxygen  concentrator  connected  to  medical  gas  pipeline
systems, providing  an  output  pressure  of  4.08--5.09  kg  cm−2
(Eniplan  Ferri  --  Engenheiros  Associados  Ferri  Lt.,  COE  2x20
model, Rio  Grande  do  Sul,  Brazil).  Nitrous  oxide  was  pro-
vided from  gas  pipeline  system  originated  from  standard
tanks.
Patients breathed  under  a  mask  with  oxygen  from  con-
centrator at  a  ﬂow  of  8.0  L  min−1 for  3  min  in  a  semi-closed
rebreathing circuit.  Following  this  period,  anesthesia  was
induced with  sequential  intravenous  administration  of  Fen-
tanyl 5.0  mcg  kg−1,  propofol  1.5  mg  kg−1 and  atracurium
0.5 mg  kg−1.  After  tracheal  intubation,  a  controlled  mechan-
ical ventilation  system  with  a  CO2 absorber  was  used  to
provide a  tidal  volume  sufﬁcient  to  maintain  exhaled  CO2
between  30  and  35  mmHg.  Maintenance  of  anesthesia  was
achieved with  isoﬂurane  and  the  FGF  of  1  L  min−1.  One
side-stream valve  (CardioCap5  --  GE  Datex-Ohmeda  Helsink,165
inlandia)  between  the  inspiratory  unidirectional  valve  and
he Y-piece  to  connect  with  the  patient  allowed  the  inspired
nd expired  fractions  of  volatile  anesthetics,  carbon  diox-
de (ETCO2),  oxygen  (FiO2)  and  nitrous  oxide  (FiN2O)  to  be
onitored, and  another  side-stream  valve  (Capnomac  --  GE
atex-Ohmeda Helsink,  Finlandia),  located  at  the  delivery
ort through  which  the  gases  are  delivered  from  the  machine
o the  systems,  monitored  the  percentage  of  oxygen  deliv-
red from  concentrator  by  means  of  paramagnetic  oxygen
nalysis. The  samples  derived  from  these  sidestream  valves
ere vented  to  atmosphere  (Fig.  1).  The  measurements  of
xygen ratios  in  either  group  were  expected  to  reach  sta-
ility, considering  the  consumption  of  oxygen  should  be  at
east 200  mL  min−1 throughout  the  intraoperative  period.
The variables  studied  were  the  concentration  of  inspired
xygen, as  well  as  the  fraction  of  inspired  oxygen  measured
very 10  min  after  intubation  until  the  end  of  anesthesia.
rterial pressure,  heart  rate  and  pulse  oximetry  values  were
btained at  the  beginning  of  anesthesia  as  well  as  every
0 min  until  the  end  of  the  procedure.  The  ratio  of  FiO2 to
xygen concentration  delivered  by  the  concentrator  (O293)
as compared  at  intervals  between  the  groups.  The  results
re presented  as  median  and  25--75  percentiles  or  mean  and
tandard deviation  when  normality  was  achieved.  Analysis
f variance  for  repeated  measures  was  used  to  compare
ata from  the  different  time  intervals  within  groups.  Stu-
ent’s t  test  was  used  to  compare  the  age,  weight,  height
nd body  mass  index.  Chi-square  was  used  to  compare  the
ender ratio.  The  hypothesis  considered  a  previous  inves-
igation with  oxygen  concentrator  as  the  sole  source  and
here the  mean  FiO2 difference  was  considered  the  target
ifference and  the  use  of  a  nomogram  for  calculating  sam-
le size  give  a  sample  of  25--30  patients.3,7 All  comparisons
ere considered  statistically  signiﬁcant  when  p  <  0.05.  The
tatistical package  Sigma  Stat  for  Windows,  version  2.03,
PPS Inc.  was  used.
esults
ixty  patients  of  both  sexes  formed  the  sample,  with  30  in
ach group,  including  ASA  physical  status  one  and  two.  There
as no  statistically  signiﬁcant  difference  between  the  two
roups for  gender,  age,  weight,  height  or  body  mass  index
Table 1).
The mean  values  and  standard  deviations  of  delivered
xygen concentration  and  inspired  oxygen  percent  were  reg-
stered for  both  groups  (Fig.  2).  There  was  no  difference  inHeight (m)  1.67  ±  0.07  1.70  ±  0.09
BMI (kg  cm−2)  23.45  ±  3.71  24.16  ±  3.74
Gender (M/F)  16/14  16/14
166  J.R.  Moll  et  al.
Figure  1  Monitoring  of  gases  in  the  respiratory  system.  Places  for  gases  monitoring:  CardioCap5  measured  fractions  of  volatile
anesthetics,  carbon  dioxide  (ETCO2),  oxygen  (FiO2)  and  nitrous  oxid
the  machine  to  the  systems.  The  samples  derived  from  these  sidestr
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the nitrous  oxide  concentration  increased.10 A  mixture  com-igure  2  FiO2/O2 ratio  over  time,  from  O293  or  in  association
ith nitrous  oxide.
0  compared  to  50  min  and  up  (Tukey  test,  p  <  0.05).  There
as also  no  difference  in  the  delivered  oxygen  concentration
ver time  for  the  fresh  oxygen  ﬂow  from  concentrator  in  the
roup receiving  oxygen  and  nitrous  oxide  (p  =  0.153).  How-
ver, FiO2 showed  a  signiﬁcant  decline,  from  52%  at  10  min  to
0% at  the  end  of  anesthesia  (p  <  0.001).  There  was  no  dif-
erence within  interval  10  throughout  40  min,  but  from  50
p to  100  min  all  values  registered  from  10  to  40  min  were
igniﬁcantly different  (Tukey,  p  <  0.05).
These measurements  reﬂected  in  the  ratio  of  fraction
nspired and  fresh  oxygen  ﬂow  (FiO2/oxygen  ﬂow)  in  both
roups. In  the  group  receiving  oxygen  from  the  concen-
rator (O293)  the  ratio  improved  over  time  (p  <  0.001).
n the  group  receiving  oxygen  and  nitrous  oxide,  the
iO2/oxygen  ﬂow  ratio  decreased  over  time  (p  <  0.001).
he inhalational  anesthetics  percentiles  were  kept  at  the
p
d
te  (FiN2O),  and  Capnomac  measured  the  gases  delivered  from
eam  valves  were  vented  to  atmosphere.
nesthesiologist  discretion  and  exhaled  CO2 were  kept
ithin the  expected  margins,  32.47  ±  1.59  mmHg  in  the
293 group,  and  32.63  ±  1.69  mmHg  in  the  O293NO  group.
Pulse  oximetry  was  lower  before  the  induction  of  anes-
hesia and  values  differed  between  groups  (97.7  ±  1.2  vs.
9.1 ±  0.5  for  O293NO  and  O293,  respectively;  p  <  0.001,
tudent t).  Following  induction  the  hemoglobin  (Hb)  satu-
ation did  not  fall  below  98.5%  in  either  group.
iscussion
his  study  showed  that  the  FiO2 in  the  mixture  of  O293  and
2O  fell  from  52%  to  41%  during  the  observation  period.  Oxy-
en saturation  was  higher  than  98.5%  throughout  the  study
nd the  ratio  of  oxygen  supplied  and  inspired  became  stable
ver time,  but  was  lower  than  one.
This  investigation  conﬁrms  stability  of  oxygen  saturation
howed by  previous  studies  using  oxygen  from  concentrators
n an  anesthesia  circuit  with  a  carbon  dioxide  absorber  and
 FGF  of  500  mL  per  minute.8,9 Although  a  fresh  oxygen  ﬂow
f up  to  0.5  L  min−1 may  result  in  a  signiﬁcant  accumulation
f argon  compared  to  higher  oxygen  ﬂows  of  1.0  and  2.0  L
er minute,10 this  study  suggests  that  both  FiO2 and  Hb  sat-
ration are  stable  over  time  when  using  a  oxygen  ﬂow  equal
o or  greater  than  0.5  L  min−1 during  general  anesthesia  of
ealthy adults  in  semi-closed  rebreathing  circuit  system.
The  association  of  oxygen  from  a concentrator  and
itrous oxide  has  previously  been  studied  under  low  FGF
nd it  was  suggested  that  the  fraction  of  argon  gas  was
mall and  prone  to  falling  between  60  and  120  min  but  thatosed of  33%  oxygen  could  threaten  the  ﬁnal  concentration
ue to  the  accumulation  of  argon.8 An  adjusted  inspira-
ory oxygen  concentration  of  35--70%  in  a  fresh  gas  ﬂow
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an oxygen concentrator as the oxygen source. TechnicalOxygen  concentrators  performance  
as  low  as  0.5  L  min−1 showed  no  complications  and  could
be considered  safe  and  without  additional  risk  of  hypoxia,
in rebreathing  systems  and  closed  circuits,  according  to
measurements of  O2 concentration  in  the  inspired  gas.11 As
pointed out,  if  the  oxygen  used  as  fresh  gas  is  from  oxygen
concentrators, argon  concentration  may  increase  as  much
as 2%.  Argon  is  inert  and  has  no  toxic  effect  on  other  gases,
e.g., oxygen  and  other  potent  inhaled  agents.12
In  the  present  investigation  the  use  of  50%  oxygen  from
a concentrator  prompted  the  FiO2 to  fall  from  52%  to  41%,
although the  ratio  of  offered  and  inspired  oxygen  reached
a plateau.  The  nitrous  oxide  uptake  by  the  patient  is  high
initially but  decreases  over  time  -- this means  that  there  will
be a  preponderance  of  nitrous  oxide  over  oxygen  in  the  gas
remaining in  the  breathing  system  after  gas  uptake  by  the
patient. This  gas  will  be  vented  to  waste  (off  the  circuit),  but
the  oxygen  concentration  in  the  system  will  fall  towards  the
fraction of  oxygen  that  remains  after  the  gas  uptake.  The
N2O  alters  the  ﬁnal  oxygen  offered  in  the  breathing  system,
since the  percentage  of  oxygen  from  the  concentrator  did
not fall  at  anytime  in  either  group.
In  contrast,  the  exclusive  use  of  oxygen  from  a  concen-
trator caused  the  FiO2 to  increase,  with  a  stable  ratio  of
offered and  inspired  oxygen.  This  behavior  is  the  result  of
nitrogen brought  to  the  breathing  system  by  the  patient  from
dissolved volumes  in  muscle  and  fat,  which  comes  out  of
solution over  the  following  hour  after  the  intubation.  This
rate of  nitrogen  excretion  decreases  over  time  --  and  this
may be  a  reason  why  the  FiO2 increased  in  the  pure  oxygen
group.
These results  may  add  to  the  literature  that  oxygen  from
concentrators are  cost-effective,  reliable  and  convenient
for supplying  oxygen,  especially  in  underdeveloped  regions
and on  low  budgets,13 presenting  results  that  suggest  oxy-
gen from  concentrator  provide  a  stable  FGF  when  added  to
nitrous oxide  50:50  volume.  Pressurized  oxygen  cylinders
are expensive  when  including  the  cost  of  transportation,
while properly  maintained  oxygen  concentrators  can  provide
a highly  effective  low-cost  and  easy-to-use  solution  for
health facilities  in  developing  countries.  A  return  on  invest-
ment may  be  achieved  within  1--2  years.14 In  describing  a
modern practice  management,  an  anesthesia  department
in an  underserved  country  hospital  established  as  a  norm
the use  of  oxygen  concentrator  in  order  to  reduce  oxygen
costs.15
The  use  of  nitrous  oxide  remains  a  source  of  contro-
versy in  anesthesia.  The  Evaluation  of  Nitrous  oxide  In  a
Gas Mixture  for  Anaesthesia  (ENIGMA)  trial  reported  that  the
use of  nitrous  oxide  increases  postoperative  complications
and may  contribute  to  neurocognitive  dysfunction  in  the
young and  elderly.  However,  current  evidence  in  support
of a  more  widespread  proscription  in  clinical  practice  is
unconvincing.16,17 Given  that  nitrous  oxide-related  anesthe-
sia casualties  are  rare  but  usually  prosecute,  they  almost
invariably attract  signiﬁcant  media  attention.18 Sweden  has
thus  ceased  the  use  of  nitrous  oxide  with  no  dissatisfaction
from anesthesiologists  and  no  increase  in  the  use  of  other
anesthetic agents,  as  expected.19 Notwithstanding,  a recent
large study  in  non-cardiac  surgery  suggests  the  use  of  this  gas
in the  intraoperative  period  was  associated  with  decreased
odds of  30-day  mortality  and  decreased  odds  of  in-hospital
mortality/morbidity.20167
Oxygen  concentrators  provide  a  consistent  and  less
xpensive source  of  oxygen  in  health  facilities  where  power
upplies are  reliable.  The  threat  of  a  hypoxic  mixture  arising
rom accumulation  of  argon  should  be  guarded  against  using
n oxygen  analyzer  in  the  inspired  gas  circuit,  as  well  as  a
ulse oximetry.
The FiO2 in  the  mixture  of  O293  and  nitrous  oxide  fell
uring the  observation  period  although  oxygen  saturation
as higher  than  98.5%  throughout  the  study.  Concentrators
an be  considered  a  stable  source  of  oxygen  for  use  during
hort anesthetic  procedures,  either  pure  or  in  association
ith nitrous  oxide  at  50:50  volume.
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